Science |Vertex
Vertex Appoints Daniel Brennan to its Board of Directors
October 20, 2026 · 4:05 PM · BOSTON
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Daniel Brennan has been appointed to its Board of Directors as an independent director. Mr. Brennan has more than 35 years of experience in finance roles at leading healthcare companies, including more than 25 years at Boston Scientific Corporation, a medical device and healthcare technology company. Mr. Brennan retired last year from serving as Boston Scientific’s Executive Vice President, Chief Fi...
- PublishedOctober 20, 2026 · 4:05 PM
- LocationBOSTON
- IndustryScience
- LanguageEN
Published by Business Wire. Read the original announcement for the full release.
Read the full announcement →